Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $46.9 Million - $53.2 Million
1,693,600 Added 124.73%
3,051,400 $88.3 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $15.3 Million - $17.9 Million
-605,200 Reduced 30.83%
1,357,800 $38 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $6.63 Million - $7.61 Million
-256,000 Reduced 11.54%
1,963,000 $54.5 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $27.9 Million - $36.2 Million
1,067,500 Added 92.71%
2,219,000 $63.9 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $29.6 Million - $34.3 Million
-820,800 Reduced 41.62%
1,151,500 $42.2 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $67 Million - $87.3 Million
-1,702,200 Reduced 46.32%
1,972,300 $80.5 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $11.3 Million - $14.7 Million
-270,400 Reduced 6.85%
3,674,500 $188 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $89.6 Million - $109 Million
2,047,700 Added 107.93%
3,944,900 $173 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $67.8 Million - $80.4 Million
1,457,700 Added 331.67%
1,897,200 $99.5 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $77.4 Million - $95.9 Million
-1,691,900 Reduced 79.38%
439,500 $22.8 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $29.1 Million - $43.1 Million
-704,100 Reduced 24.83%
2,131,400 $126 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $78.9 Million - $101 Million
2,009,500 Added 243.28%
2,835,500 $122 Million
Q2 2021

Sep 13, 2021

BUY
$35.91 - $40.68 $29.7 Million - $33.6 Million
826,000 New
826,000 $32.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.